Why I’d sell Fevertree Drinks plc’s explosive growth for A.G. Barr plc’s dividend

One Fool believes excessive market expectations stack the odds against Fevertree Drinks plc (LON: FEVR), but low expectations for A.G. Barr plc (LON: BAG) are an opportunity

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Fevertree Drinks (LSE: FEVR) is perhaps one of the UK’s most compelling growth stories. The business has not just dominated a niche, but has carved out a new one by offering premium mixers to accompany expensive spirits. 

I significantly underestimated the market for premium mixers when Fevertree first appeared on the scene. Perhaps I still do, because I don’t believe the company worth buying at current prices despite 77% revenue growth and a doubling of diluted EPS in the first half of this year. 

That said, I’m not horribly bearish on the company. The business model is wonderful – it outsources manufacturing which does away with the need to invest heavily in bottling plants. That’s why profits tend to grow faster than revenue at the company. The fixed cost base is relatively low, so incremental sales growth flows through to the bottom line. 

Cash generation is incredibly strong and net cash now sits at £40m. As a result, the interim dividend has been hiked 95%. Even after this massive increase, the shares still only offer a 0.57% yield to prospective investors.

A low yield is largely irrelevant given the growth nature of the company, although it serves to illustrate just how pricey the shares are. Everyone knows Fevertree is a wonderful business and its valuation has been driven up to 63 times forward earnings as people scramble for the shares.

To be fair to the bulls, it regularly smashes earnings predictions, which might explain why the share price has retreated a little recently, despite management predictions to “materially beat expectations for the year.

Can I see myself owning shares in Fevertree one day? Absolutely. But I feel patience is perhaps the best course of action right now considering the heady valuation and expectations placed on the firm. Instead, I’m more tempted by A.G. Barr (LSE: BAG).

Seizing market share

Adjusted figures almost always used to put a company’s best foot forward, to flatter results. Not so at Barr, a class act that adjusted out an exceptional gain from the sale of its Walthamstow facility to ensure results didn’t overstate the performance of the underlying business. 

This honestly doesn’t surprise me given the nature of its management team. They have rewarded shareholders generously with share buybacks and dividends in recent years. Right now, the company is executing a £30m purchase of shares and offers a 2.5% yield after hiking the interim dividend by 5%. 

I believe now is a great time for management to be buying back shares. The company’s portfolio of loved brands, including Irn Bru, Rubicon and Strathmore, are gaining market share while group revenue increased 8.8% even though the UK market expanded only 4.2% by value. The company’s project to reduce sugar levels in these drinks is storming ahead, with at least 90% of company-owned brands on track to contain less than 5g of total sugars per 100ml by January. 

You can buy the shares for only 20 times earnings. Given the company’s perennial ability to adapt to and outperform the soft drinks market, its cash-generative brands, and solid capital allocation history, that seems a fair price.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Zach Coffell has no positions in any companies mentioned. The Motley Fool UK has recommended AG Barr. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »